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Introduction
Regenerative medicine can accelerate the healing of tis-
sues that are unable to repair themselves. Embryonic and
somatic stem cells have the potential for self-renewal
and differentiation, and show great promise for clini-
cal usage. Hematopoietic stem cells (HSCs) are currently
used in clinical stem cell transplantation [1]. However,
it is difficult to expand CD34+ HSCs and to maintain
them undifferentiated. A better understanding of the
mechanisms regulating “stemness” is needed in order
to improve our ability to utilize HSCs more effectively.
HSC isolation is performed by making use of the
CD34 antigen [2,3]. Bone marrow, peripheral blood
and cord blood are all excellent sources of CD34+
HSCs. However, the CD34+ population also contains
few lineage-committed progenitors that are directly
responsible for the generation of mature blood cells or
endothelial cells. For example, the CD133+/VEGFR3+
subpopulation was defined as precursors of lymphatic
endothelial cells [4], and CD133+/VEGFR2+ cells were
also identified as functional endothelial precursors in
circulating human CD34+ cells [5]. Thus, CD34 is usually
combined with other selection markers for the isola-
tion of HSCs [6]; long-term and short-term functional
HSC are identified by the surface markers CD34+
CD33−CD38−Rholow and CD34+CD33−CD38−Rhohigh,
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SUMMARY
Objective: Somatic CD34+ hematopoietic stem/precursor cells (HSPCs) give rise to hematopoietic cells and
endothelial cells and have been used in clinical applications. Understanding the genes responsible for stemness
and how they interact with each other will help us to manipulate these cells more efficiently in the future.
Materials and Methods: We performed microarray analysis on human CD34+ HSPCs and on two different
progeny cell types, i.e. microvascular endothelial cells and peripheral blood mononuclear cells. Systems biology
and advanced bioinformatics tools were used to help clarify the genetic networks associated with these stem
cell genes.
Results: We identified CD34+ HSPC genes and found that they were involved in critical biologic processes such
as cell cycle regulation, chromosome organization, and DNA repair. We also identified a novel precursor gene
cluster on chromosome 19p13.3. Analysis of HSPC-enriched genes using systems biology tools revealed a com-
plex genetic network functioning in CD34+ cells, in which several genes acted as hubs to maintain the stability
(such as GATA1) or connectivity (such as hepatic growth factor) of the whole network.
Conclusion: This study provides the foundation for a more detailed understanding of CD34+ HSPCs. [Taiwan J
Obstet Gynecol 2008;47(4):422–430]
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respectively. The CD133 antigen has also recently been
used for HSC isolation [7,8].
The gene expression patterns in human and mouse
CD34+ hematopoietic stem/precursor cells (HSPCs)
have been widely characterized by serial analysis of gene
expression or microarray analysis in several studies, which
have identified genes involved in self-renewal, differen-
tiation and lineage choice [2,3,6,9–13]. However, assign-
ing biologic significance to these genes remains difficult.
In this post-genomics era, modern bioinformatics and
systems biology tools can help to predict the biologic
behaviors of gene products. Deductions about de novo
gene relationships can be made using exploratory com-
putational tools and systems biology algorithms, and
can provide a systematic approach for discovering novel
molecular events and relationships [14,15]. The com-
bination of microarray and computational results will
enable biologists to speed up their research.
This study aimed to identify the genes responsible
for the stem cell properties of CD34+ HSPCs, and to pro-
vide a global genetic network for them. We compared
the gene expression profile of CD34+ HSPCs to those
of their matured progenies, including endothelial cells
and hematopoietic cells. This is a novel strategy that
has not been used before.
Materials and Methods
CD34+ cells and primary microvascular endothelial
cells (MVECs)
Human CD34+ cells from healthy individuals were iso-
lated from bone marrow, peripheral blood or cord
blood (Poietics; Cambrex, USA). In order to induce
endothelial differentiation, isolated CD34+ cells were
plated onto fibronectin-coated wells (Sigma-Aldrich,
St Louis, MO, USA) and maintained in endothelial
basal medium-2 (EBM2) supplemented with EGM2-MV
SingleQuots (Clonetics Cambrex, Emerainville, France).
Microarray analysis was performed using CD34+ cells
from bone marrow and peripheral blood, while those
from cord blood were processed for quantitative real-
time reverse transcription polymerase chain reaction
(RT-PCR) analysis. Human primary MVECs (Clonetics
Cambrex, Emerainville, France) and the human endo-
thelial cell line HMEC1 were cultured in EGM-2 MV
BulletKit medium (Cambrex, Walkersville, MD, USA).
Real-time RT-PCR and cyber green quantitative
polymerase chain reaction (qPCR)
For real-time RT-PCR, primers and probes for the human
glyceraldehyde 3-phosphate dehydrogenase gene (endo-
genous control) were designed using the Primer Express
software program (Applied Biosystems, Foster City,
CA, USA). Specific products were detected and ana-
lyzed using a Perkin-Elmer 7900 sequence detector
(Applied Biosystems, Foster City, CA, USA).
Array probe preparation, data analysis, and functional
network analysis
Total RNA collection, complementary RNA probe prepa-
ration, array hybridization and data analysis were per-
formed as previously described [16]. Expression profiles
of CD34+ HSPCs, MVECs and peripheral blood mono-
nuclear cells were identified using the Affymetrix HG-
U133 Plus 2.0 (Affymetrix, Santa Clara, CA, USA). Gene
annotation enrichment analysis was performed using the
DAVID 2007 tool (http://david.abcc.ncifcrf.gov/) [17].
EASE score, a Fisher’s exact test-based scoring system,
was used to calculate p values, determining the proba-
bility that the number of genes was specifically enriched
in a given gene ontology (GO) or occurred by random
chance. The Ingenuity Pathway Analysis (IPA) web tool
developed by Ingenuity Co. (www.ingenuity.com) was
used to construct functional regulatory networks of
gene profiles. IPA uses the Ingenuity Pathways Knowl-
edge Base to identify known interactions between focus
genes and other genes that are not in the gene list. IPA
then determines a statistical score for each network
according to the fit of the network to the set of focus
genes. The score is the negative log of p and denotes
the likelihood of the focus genes in the network being
found together by chance.
Results
Molecular signatures of CD34+ HSPCs
To access molecular signature genes for CD34+ cells,
we obtained CD34+ HSPCs from human bone marrow
and granulocyte-macrophage colony-stimulating factor-
mobilized peripheral blood from healthy individuals.
When freshly isolated CD34+ cells were subjected to en-
dothelial differentiation conditions for 14 days [18,19],
endothelial-like cells formed characteristic capillary
tube structures, suggesting the presence of endothelial
stem/precursor cells in the CD34+ cell preparations. We
also obtained human dermal MVECs that were posi-
tive for the endothelial cell markers, CD31 and von
Willebrand factor.
The gene expression profiles of HSPCs and MVECs
were determined and compared with each other. CD34+
cells can also give rise to hematopoietic cells, and
peripheral blood mononuclear cells were, therefore,
also included in the comparison. The gene expression
profiles of these three cell types were identified at least
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in triplicate, using the Affymetrix™ HG-U133 Plus 2.0
whole-genome chip. According to the statistical meth-
ods used previously [16], genes differentially expressed
between each cell type (the molecular signature) were
identified. A total of 1,282 probe sets (corresponding to
1,042 genes) were uniquely expressed in CD34+ HSPCs
(with a false-positive discovery rate threshold q <0.001).
All but five of these signature genes showed at least a
1.5-fold expression difference when compared with the
other cell types. A gene expression heatmap for this sig-
nature indicated its unique expression pattern in CD34+
HSPCs (Figure 1A). Its discriminant ability was also
assessed using multidimensional scaling (Figure 1B).
GO mapping of differentially expressed HSPC genes
There were 439 probe sets (345 genes) specifically en-
riched in CD34+ cells (Figure 1A), and these were most
likely to be involved in self-renewal and cell proliferation.
To gain more insights into their functional roles in CD34+
cells, these 439 probe sets were subjected to a GO data-
base search [20] to identify statistically over-represented
functional groups within this gene list. The DAVID 2007
web-based tool, a graph theory evidence-based method
to agglomerate gene/protein identifiers [17], was used
for this task. Because the chip we used represented the
whole human transcriptome, this analysis was not
biased toward the coverage of the microarray.
The GO tree of biologic processes that were statis-
tically over-represented (p < 0.05) is shown in Table 1.
The predominant processes included those pertaining
to the cell cycle (especially M phase), DNA and RNA
metabolism (replication and transcription), chromo-
some organization and biogenesis, cell proliferation, and
DNA repair. Genes belonging to broad biologic process
categories are summarized in Table 2. Many of these
CD34+ cell-enriched genes have previously been identi-
fied as HSC-specific gene products, using a global sub-
tractive hybridization screen [21] or by other microarray
analyses [2,3,6,9–13]. GATA2, KIT and MYB were
shown to be enriched in pluripotent HSCs [22–24].
PROM1 (CD133) is also known as a hemangioblast
marker [8]. GATA1 has been identified as an erythroid-
specific transcription factor essential during the rela-
tively early stages of erythrocytic differentiation [25].
GATA1 and RUNX1 are coexpressed and cooperate in
megakaryocytic differentiation [26]. Defective vascular
remodeling in RUNX1 homozygous mutant mice could
be rescued by the addition of HSCs or angiopoietin-1,
supporting the role of angiopoietin-1 secreted by HSCs
in angiogenesis [27]. Many other known HSC markers,
such as FLT3, KLF1, LMO2 and PBX1, were also present.
These consistent findings demonstrated the reliability
of our gene list (Table 2, italics).
Chromosomal locations of CD34+ signature genes
A significant number of CD34+ cell-enriched genes were
located at cytoband 19p13.3 (11 genes; p = 0.00002;
Figure 2A). Among them, the genes for azurocidin
(AZU1), neutrophil elastase (ELA2) and proteinase-3
(PRTN3) encoded primary components of neutrophil
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Figure 1. Characterization of CD34+ hematopoietic stem-progenitor cells (HSPCs) and primary microvascular endothelial
cells (MVECs). (A) A heatmap shows genes enriched in CD34+ HSPCs. Red indicates increased gene expression; blue indicates
decreased gene expression. (B) A multidimensional scaling (MDS) plot shows the discriminant ability of the obtained molecular
signatures for cell groups. Each spot represents a single array sample.
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azurophilic granules [28] and were closely located in a
region of approximately 50 kb (Figure 2B). These genes
have been shown to be expressed in a coordinated fash-
ion, and changes in chromatin organization at this locus
are associated with myeloid cell differentiation [28]. We
additionally found that an adjacent gene, that for bone
marrow proteoglycan 2 (PRG2), was also upregulated
in CD34+ cells (Figure 2B).
Coordinated changes in functional networks of CD34+
signature genes
In order to understand how genes enriched in CD34+
cells are related, we performed functional network analy-
sis using the IPA web tool and the Ingenuity knowledge
database (see Materials and Methods). Two major
networks and three interacting pairs were identified
(Figure 2A). One of the major networks (33 genes) in-
cluded most of the known stemness-related or pro-
proliferation genes. Among these CTSG (cathepsin G),
a member of the peptidase S1 protein family encoded on
chromosome 14q11.2, is another azurophil granular pro-
tein. GATA1 and KLF1 (EKLF) are precursors and de-
finitive differentiation-associated genes; HGF (hepatic
growth factor) and KIT are HSC-associated genes;
GATA2, LMO2, MPO and MYB support self-renewal and
keep HSCs in an undifferentiated state; FOXO3A and
PLAGL1 are involved in inhibition of the cell cycle [29].
CDK6 is a factor promoting the G1 phase in HSCs [30].
In addition to confirming what was already known
about CD34+ HSPCs, novel genes that may play cru-
cial roles in self-renewal and differentiation were also
revealed. Genes not previously implicated in stemness,
Table 1. Biologic processes enriched in CD34+ hematopoietic stem-progenitor cells (HSPCs). Selected biologic processes 
over-represented by genes enriched in CD34+ cells. A total of 439 probe sets enriched in CD34+ cells were subjected to 
DAVID 2007 analysis. These categories were selected from the biologic process organizing principle in the Gene Ontology 
project. The number of genes, their percentage in those 439 probe sets, and p values for each category that was signifi-
cantly (p < 0.05) over-represented are listed
Biological process Gene no. % p
Metabolism
Nucleo-base, -side, -tide and nucleic acid metabolism 96 24.2 6.54 × 10−8
DNA replication 19 4.8 5.41 × 10−9
DNA-dependent DNA replication 13 3.3 2.92 × 10−8
DNA replication initiation 8 2 2.23 × 10−7
Transcription 57 14.4 3.18 × 10−3
Transcription, DNA-dependent 45 13.6 2.30 × 10−3
DNA metabolism 32 8.1 6.54 × 10−8
Nucleotide metabolism 10 2.5 1.20 × 10−3
Cellular metabolism
Regulation of cellular metabolism
Positive regulation of cellular metabolism 8 2 1.43 × 10−2
Cellular biosynthesis 34 8.6 9.66 × 10−3
Biopolymer metabolism 61 15.4 2.03 × 10−3
Regulation of metabolism 61 15.4 1.39 × 10−3
Biosynthesis 35 8.8 2.46 × 10−2
Cellular physiologic process
Cell cycle
Regulation of cell cycle 15 3.9 2.06 × 10−2
M phase 9 2.3 1.43 × 10−2
Cell organization and biogenesis
Organelle organization and biogenesis
Chromosome organization and biogenesis
Chromosome organization and biogenesis (sensu Eukaryota) 10 2.5 4.58 × 10−2
Response to endogenous stimulus 11 2.8 1.43 × 10−2
Response to DNA damage stimulus 10 2.5 2.45 × 10−2
DNA repair 10 2.5 1.37 × 10−2
Regulation of physiologic process 73 18.4 1.05 × 10−2
Taiwan J Obstet Gynecol • December 2008 • Vol 47 • No 4426
S.J. Chang, et al
but crucial in carcinogenesis, were identified, including
BRCA1, CDH1, ELF2, JUND, TACSTD1 and MSH6.
Similarly, genes without previously known roles in hema-
topoiesis or endothelial differentiation but with known
roles in the development of other organs, including
NCL, PIK3R1, THRB1 and TRH, were identified [31,32].
NR1I2 (PXR), UQCRH (ubiquinol-cytochrome-c reduc-
tase hinge protein) and WEE1 (an anti-apoptotic pro-
tein involved in the DNA damage checkpoint), whose
functions have not previously been linked to stem cell
activities, were also shown. The network also revealed
five genes whose roles may be more crucial than others
in CD34+ cells; GATA1, HGF, MYB, THRB and RUNX1
were the “hub” genes (genes involved in most interactions
with other components) that either preserved the stabil-
ity of the whole network or linked sub-modules in the
same network to each other.
Another major network contained genes mainly
involved in minichromosome maintenance (MCM) and
DNA replication, including CDT1, MCM2, MCM3,
MCM4, MCM5, MCM6, MCM7 and ORC1L (eight
genes; Figure 3A). The upregulation of these S-phase 
inducers [33] suggests that a portion of CD34+ cells
may enter the cell cycle. Consistent with this, the M-
phase potential of CD34+ cells was indicated by high
expression levels of genes crucial in M phase mitosis
(p=1.43×10−2; Table 1).
Abundant expression of some network genes (includ-
ing GATA1, JUND and MCM5) in CD34+ cells was ver-
ified by qPCR (Figure 3B). The qPCR results showed 
a high degree of correlation with microarray results
(r ≥ 0.95).
Discussion
Stem cells are currently attracting much attention be-
cause of their unique biologic behavior and potential
clinical usefulness. In this study, we performed exten-
sive comparative transcriptomic and gene network analy-
ses of CD34+ HSPCs. The results will help to unravel the
riddle of HSPCs and contribute to cell-based therapy.
In addition to identifying specific genes, we also used
refined computational methods to highlight key func-
tional networks. There is increasing recognition that a
systematic approach is necessary to achieve an overview
Table 2. Genes enriched in CD34+ HPCs
Cell cycle/cell proliferation CDCA7, CDK6, CDT1, CHAF1A, DDX11, DKC1, DNTT, DUT, KNTC1, MCM2, MCM3,
MCM4, MCM5, MCM6, MCM7, MSH6, ORC1L, PLAGL1, POLD1, PPP3R1, RCC2,
RFC3, SET, SMC2L1, TFDP2, TOP1MT, TSGA2, WEE1
Cytokines & cognate ANGPT1, FLT3, HGF, KIT, NENF, TFR2, THRB, TMPO
receptors
Response to DNA damage APEX1, BRIP1, FANCL, PMS2L1, RAD51AP1, TRH, UNG
stimulus
Cell adhesion CDH1, CLDN10, COL14A1, COL24A1, DSG2, EPDR1, GMDS, ICAM4, ITGA9, PRG2
Transcription ADNP, BRCA1, CHD4, ELF2, ETV6, FOXO3A, GATA2, JUND, KCNH2, L3MBTL4, 
LOC148203, LYL1, MLF1IP, MXD3, MYB, NR1I2, NRIP1, NSBP1, PHB2, PRDM16,
RAI17, SSBP2, TGIF2, YEASTS2, ZNF6, ZNF44, ZNF135, ZNF334, ZNF667
Protein metabolism APOC1, CPXM, CTSG, DARS, DPEP3, ELA2, FBXO11, HS6ST1, NEDD4L, PRSS21,
PRTN3, PTPMT1, PTPRD, RHAG, RPL7A, RPL15, RPL18A, RPS10, RPS15A, RPS17,
STT3B, TPSAB1, ZNRF1
Development APOE, AZU1, CHRM3, CLGN, DACH1, DPPA4, DNMT3B, EREG, ETS2, FZD7, GATA1,
HESX1, HLF, KLF1, LMO2, MAML3, MAP7, MPPED2, NDN, NPR3, PBX1, PHGDH,
PROM1 (AC133), REC8L1, RTN4R, RUNX1, SCML2, SLC22A16, SPATA11, SPTA1,
ST6GAL2, TMPRSS6, TRO, WHSC1
Signal transduction ASB13, CRHBP, DEPDC1B, DEPDC6, GNB1, GPSM2, GUCY1A3, HTR1F, KCNK17,
LGR7, NET1, NPW, PDZK3, PDZK8, PGDS, RAB7B, SUCNR1, TGFBRAP1
Transport EMID1, HBD, RYR3, SFXN2, SFXN4, SHMT1, SLC16A14, SLC18A2, SLC1A6, 
SLC22A16, SLC25A15, SLC25A27, SLC27A2, SLC27A5, SLC2A5, SLC39A3, SLC39A4,
SLC43A1, SLC7A5, SLC8A3, SLC9A3, SNX26, SV2A
Others B4GALT6, C5orf13, CALN1, Cep70, CRISPLD1, DNAJA5, ENO1, EXOSC4, HNRPA0,
HNRPA1, HPRT1, KLHL23, MGC21644, MNS1, MPO, MSI2, MUC1, PPP1R13B,
RNF24, SEPP1, SESN3, SNRPD1, SNRPE, SS18, TCBA1, YPEL2, ZBED3
Genes are represented by the HGNC official symbols (www.gene.ucl.ac.uk/nomenclature/). Genes discussed in the text are in italics.
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of the molecular events responsible for a given biologic
process [34,35]. In this study, we used systems biology
tools to reveal the interactions between CD34+ signature
genes. Two functional networks and three interacting
pairs of CD34+ HSPCs-enriched genes were identified,
though only 9.6% of CD34+ genes were involved (Figure
3A). The genetic networks, which were identified by in
silico approaches based on knowledge-based databases,
provided further information (such as key hub genes)
that could not be readily extracted using one-dimensional
gene list analysis. For example, GATA1 plays an essen-
tial role in the promotion of hematopoietic cell differ-
entiation [25], but GATA2 blocks cells differentiation
and stimulates the proliferation of immature cells [24].
Differential expression of the GATA2 and MYB genes
also correlates with the potential of α4-integrin+
embryonic stem cells to differentiate into hematopoietic
cells [23,36].
Our analyses have limitations: the functional net-
works were mapped based on pre-existing knowledge
databases (GO and IPA), in which molecular interac-
tions were established in various physiologic or patho-
logic conditions. It is known that molecular functions
vary depending on cellular and tissue contexts, and the
stemness genes may, therefore, not interact in a similar
way in human CD34+ cells. Functional analyses will be
needed for the rigorous evaluation of individual gene
interactions deduced by an in silico modeling approach.
The functions of many of the genes found to be
enriched in CD34+ cells remain unknown. This study pro-
vides a novel strategy that can be used in further genetic
network studies on CD34+ HSCs. The methods used can
also be applied to the analysis of differentiation and self-
renewal paradigms in other stem cells, and for the analy-
sis of many other complex biologic processes, such as
tumorigenesis.
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Figure 2. A novel gene cluster identified in CD34+ hematopoietic stem-progenitor cells (HSPCs). (A) Distribution of CD34+
HSPC-enriched genes on human chromosomes. A total of 439 probe sets enriched in CD34+ cells were subjected to DAVID
2006 analysis. The number of genes, their percentage in those 439 probe sets, and p values for each cytoband that was signif-
icantly (p < 0.05) over-represented are all listed. (B) Chromosomal location of a gene cluster in CD34+ HSPCs. The cytoband
containing the most stemness genes was 19p13.3. Of those 11 genes, four, including AZU1, ELA2, PRG2 and PRTN3 (in
gray), were closely linked in a region of approximately 50 kb (810–760 kb).
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